⌘K

Login Start Free

Home/Filings/4/0001214659-22-008169

4//SEC Filing

WITTE OWEN N. 4

Accession 0001214659-22-008169

CIK 0001737287other

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:58 PM ET

Size

6.7 KB

Accession

0001214659-22-008169

Insider Transaction Report

Form 4

Period: 2022-06-15

Allogene Therapeutics, Inc.ALLO

Director

Transactions

Award
Common Stock
2022-06-15+22,089→ 243,271 total
Award
Stock Option (Right to Buy)
2022-06-15+35,535→ 35,535 total
Exercise: $9.62Exp: 2032-06-15→ Common Stock (35,535 underlying)

Footnotes (1)

[F1]Vesting in 12 equal monthly installments.

Documents

1 file

4
marketforms-56490.xmlPrimary
PRIMARY DOCUMENT

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1

filerCIK 0001700969

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 4:58 PM ET
Size: 6.7 KB

View on SEC.gov